Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-002149
Filing Date
2024-01-12
Accepted
2024-01-12 16:49:20
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 ny20018157x1_s3.htm S-3 307584
2 EXHIBIT 5.1 ny20018157x1_ex5-1.htm EX-5.1 9801
3 EXHIBIT 23.1 ny20018157x1_ex23-1.htm EX-23.1 1899
4 EXHIBIT 23.2 ny20018157x1_ex23-2.htm EX-23.2 2556
5 FILING FEES TABLE ny20018157x1_ex107.htm EX-FILING FEES 22317
6 ny20018157x1_ex5-1img01.jpg GRAPHIC 67947
  Complete submission text file 0001140361-24-002149.txt   439151
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276493 | Film No.: 24532607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)